siRNA, Anti-Human FASLG, 2'-F(CAT#: SIRGT02239WQ-2F)
The product SIRGT02239WQ-2F is a type of small interfering RNA (siRNA) that targets FASLG gene and regulates the expression of gene. The siRNA interferes with the expression of FASLG gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| Modification | 2ʹ-deoxy-2ʹ-fluoro (2'-F) |
| Scale | 20/50/100/200 nmole |
| NCBI RefSeq | NM_000639.2; NM_001302746.1 |
| Alternative Names | ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A |
| Related Diseases | Autoimmune Lymphoproliferative Syndrome, Lung Cancer |
| Purification | HPLC |
